arrow
E

Elisabeth I. Minder

triemli hospital
H指数:29
被引数:3,980

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria
2020-06-11389
OAAI
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks
2019-11-07112
OAAI
Disease Characteristics of Acute Hepatic Porphyria Patients: ENVISION, a Phase 3 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
2019-10-011
PREAI
Management of acute hepatic porphyria attacks in europe and united states: EXPLORE international, prospective, natural history study
2019-04-010
PREAI
Acute hepatic porphyria disease manifestations and daily life impacts in EXPLORE international, prospective, natural history study
2019-04-010
PREAI
EXPLORE: A prospective, multinational natural history study of patients with acute hepatic porphyria with recurrent attacks
2018-04-011
OAAI
Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane synthase is associated with liver cancer in acute porphyrias
2015-03-0121
PREAI